1.Sales and profit
See section β- Origin Agritech LTD had $12.7M of revenue in fiscal 2025, down 19.6% on the year before. Over five years, revenue changed +11.1% a year on average.
- Origin Agritech LTD lost $7.4M in fiscal 2025.
SEED Nasdaq Agricultural Production-Crops Financials FY2016βFY2025
Origin Agritech LTD had $12.7M of revenue in fiscal 2025, down 19.6% on the year before. Over five years, revenue changed +11.1% a year on average.
Hi! I read Origin Agritech LTDβs latest annual report (fiscal 2025). Here is what stands out:
Good So-so Weak
Are sales growing?
β19.6%
No. Sales fell 19.6% last year.
Does it make a profit?
β58.4%
No. It lost money last year.
Does profit turn into cash?
β37.3%
No. It spent more cash than it brought in.
How healthy are the accounts?
2 / 9
Weak. It passes 2 of 9 health tests.
Rules of thumb on reported numbers. A starting point, not a recommendation.
Is it selling more, and how much does it keep?
KIRA Β· Origin Agritech LTD had $12.7M of revenue in fiscal 2025, down 19.6% on the year before. Over five years, revenue changed +11.1% a year on average.
In plain words: Revenue is all the money customers paid. The margins show how many cents of each dollar of sales are left over at each step: after making the product (gross), after running the business (operating) and after everything, tax included (net).
KIRA Β· Origin Agritech LTD lost $7.4M in fiscal 2025.
Loss periods are shown in red.
In plain words: Net income is the profit left after every cost and tax. Earnings per share (EPS) splits that profit across every share, so it shows what one share earned.
How much cash comes in, and where does it go?
KIRA Β· Free cash flow was β$4.7M in fiscal 2025, β37.3% of revenue.
Cash from operations minus capital spending.
In plain words: Profit on paper is not the same as cash in the bank. Free cash flow is the cash left after paying to run and maintain the business: the money it can hand back to shareholders, save or invest.
KIRA Β· Origin Agritech LTD returned $0.2M to shareholders in fiscal 2025. The diluted share count rose 15.9%.
In plain words: Companies hand cash back in two ways: dividends (cash paid to shareholders) and buybacks (buying back their own shares, so each remaining share owns a bigger slice).
KIRA Β· No open-market insider trades in the last 12 months.
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. βPlanβ marks trades under a pre-arranged Rule 10b5-1 plan.
In plain words: Insiders are the people who run or own a big part of the company. Buying with their own money can signal confidence; selling often has personal reasons, like taxes or diversifying.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Can it carry its debts, and how well does it use its money?
KIRA Β· Origin Agritech LTD owes $0.4M more than it holds in cash.
Cash, debt and the ratios that show how comfortably Origin Agritech LTD can carry it.
In plain words: What the company owns and what it owes. More cash than debt is a cushion for bad times; a lot of debt leaves less room when business slows down.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $2.4M | $2.5M | $3.2M | $1.2M | $2.2M |
| Debt incl. finance leases | $21.3M | $19.3M | $0.8M | $2.2M | $2.6M |
| Current ratio | 0.2x | 0.3x | 0.5x | 0.5x | 0.4x |
| Quick ratio | 0.2x | 0.3x | 0.4x | 0.5x | 0.3x |
| Total assets | $18.4M | $19.1M | $32.7M | $18.8M | $14.1M |
| Total liabilities | $47.1M | $43.4M | $43.8M | $27.1M | $22.8M |
| Shareholders' equity | β$21.8M | β$18.8M | β$7.9M | β$4.5M | β$3.3M |
| Net debt (β = net cash) | $18.9M | $16.9M | β$2.4M | $1.0M | $0.4M |
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
In plain words: How much profit the business makes on the money put into it. A higher percentage means each dollar invested works harder.
KIRA Β· Origin Agritech LTD passes 2 of 9 financial health tests (Piotroski F-score).
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
In plain words: Nine yes/no tests of financial health, one point each. A green tick is a pass: 7 to 9 points is solid, 0 to 3 is weak.
| Test | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β | β | β | β |
| F-score | β / 3 | 1 / 9 | 4 / 9 | 3 / 9 | 3 / 9 | 3 / 9 | 7 / 9 | 4 / 9 | 4 / 9 | 2 / 9 |
| Accruals ratio | β13.2% | 7.2% | β39.5% | β0.6% | β30.7% | β36.6% | β7.8% | 33.3% | 19.3% | β25.7% |
| Altman Z'' | β1.88 | β | β | β | β | β | β | β | β | β |
Every number, year by year.
Amounts in USD. Hover a ratioβs name for its definition.
In plain words: Every number we have, year by year. Download it as a spreadsheet if you want to dig deeper.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $0.1M | $0.1M | $2.0M | $13.4M | $7.5M | $7.1M | $8.0M | $13.2M | $15.7M | $12.7M |
| Net interest income | β | β | β | β | β | β$1.3M | β$1.3M | β$0.1M | β | β |
| Provision for credit losses | β | β | $0.0M | $0.0M | $4.0M | $0.6M | β | β | β | β |
| Gross profit | $0.1M | $0.0M | $0.9M | β$1.9M | $0.5M | $2.0M | $2.5M | $2.4M | $2.2M | $0.9M |
| Research and development | $6.3M | $5.7M | $4.1M | $1.9M | $0.6M | $0.3M | $1.1M | $1.1M | $1.4M | $1.8M |
| Operating income | β$9.4M | β | β | β | β | β | β | β | β | β |
| Interest expense | $1.2M | $1.3M | $3.5M | $0.7M | $0.8M | $1.3M | $1.3M | β | β | β |
| Pretax income | β$11.2M | β$17.9M | β$23.4M | β$9.5M | β$14.6M | β$19.5M | $0.4M | $8.9M | $2.6M | β$8.1M |
| Income tax | $0.0M | $0.0M | $0.0M | $0.1M | $0.1M | $0.0M | β$0.0M | $0.0M | $0.0M | β$0.0M |
| Net income | β$10.0M | β$11.1M | β$23.5M | β$9.0M | β$12.2M | β$14.1M | β$1.0M | $7.8M | $2.9M | β$7.4M |
| Diluted EPS | β$0.44 | β$0.48 | β$7.67 | β$2.16 | β$2.42 | β$2.50 | β$0.17 | $1.19 | $0.44 | β$0.99 |
| Diluted shares | 0.00B | 0.00B | 0.00B | 0.00B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B |
| Cash flow | ||||||||||
| Cash from operations | $7.3M | β$17.6M | β$1.5M | β$8.7M | β$0.8M | β$3.9M | $0.5M | β$0.8M | β$2.1M | β$3.2M |
| Capital expenditure | $2.4M | $0.4M | $0.5M | $0.0M | $0.0M | $0.1M | $0.1M | $1.3M | $0.7M | $1.6M |
| Free cash flow | $4.9M | β$18.0M | β$2.0M | β$8.7M | β$0.8M | β$4.0M | $0.4M | β$2.0M | β$2.8M | β$4.7M |
| Depreciation and amortization | $4.8M | $4.1M | $2.5M | $2.0M | $1.5M | $1.3M | $0.6M | $0.6M | $0.4M | $0.4M |
| Stock-based compensation | $1.3M | $0.8M | $0.7M | $1.8M | $1.9M | $1.7M | $0.2M | $0.2M | $0.7M | $3.2M |
| Dividends paid | β | β | β | β | β | β | $0.4M | $0.0M | $0.1M | $0.2M |
| Dividends and buybacks | β | β | β | β | β | β | $0.4M | $0.0M | $0.1M | $0.2M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $8.2M | $0.5M | $0.3M | $0.4M | $3.3M | $2.4M | $2.5M | $3.2M | $1.2M | $2.2M |
| Total debt | $22.8M | $16.1M | $11.4M | $11.0M | $20.2M | $21.3M | $19.3M | $0.8M | $2.2M | $2.6M |
| Current assets | $71.7M | $13.4M | $31.2M | $9.7M | $9.5M | $9.0M | $11.5M | $19.4M | $14.2M | $9.3M |
| Current liabilities | $92.1M | $20.2M | $62.8M | $34.7M | $26.0M | $44.3M | $41.2M | $42.9M | $26.3M | $21.0M |
| Inventory | $0.1M | $3.5M | $11.9M | $4.0M | $2.0M | $0.6M | $0.3M | $1.8M | $1.8M | $2.0M |
| Property and equipment, net | $22.8M | $26.7M | $25.1M | $20.9M | $17.0M | $7.5M | $6.5M | $2.9M | $4.0M | $4.0M |
| Goodwill | $1.8M | β | β | β | β | β | β | β | β | β |
| Intangible assets | $2.2M | $2.9M | $2.4M | $1.8M | $1.4M | $0.3M | $0.3M | $0.4M | $0.5M | β |
| Total assets | $132M | $48.7M | $62.5M | $36.6M | $37.4M | $18.4M | $19.1M | $32.7M | $18.8M | $14.1M |
| Total liabilities | $99.2M | $31.8M | $65.9M | $38.7M | $50.0M | $47.1M | $43.4M | $43.8M | $27.1M | $22.8M |
| Preferred stock | $0.0M | $0.0M | $0.0M | $0.0M | β | β | β | β | β | β |
| Shareholders' equity | $27.0M | $16.9M | β$3.6M | β$3.2M | β$11.3M | β$21.8M | β$18.8M | β$7.9M | β$4.5M | β$3.3M |
| Margins | ||||||||||
| Gross margin | 100.0% | 22.1% | 45.5% | β13.9% | 6.7% | 27.6% | 30.8% | 18.5% | 14.2% | 7.0% |
| Operating margin | β12,749.0% | β | β | β | β | β | β | β | β | β |
| EBITDA margin | β6,256.4% | β | β | β | β | β | β | β | β | β |
| Net margin | β13,637.0% | β8,697.9% | β1,188.7% | β67.2% | β162.4% | β197.2% | β11.9% | 59.3% | 18.3% | β58.4% |
| FCF margin | 6,694.2% | β14,113.4% | β100.8% | β65.0% | β10.7% | β55.6% | 5.1% | β15.4% | β17.6% | β37.3% |
| Net interest share of revenue | β | β | β | β | β | β18.4% | β15.6% | β1.1% | β | β |
| Returns | ||||||||||
| Return on capital | β17.8% | β | β | β | β | β | β | β | β | β |
| Return on capital employed | β23.5% | β | β | β | β | β | β | β | β | β |
| Return on equity | β37.1% | β50.6% | β353.4% | β | β | β | β | β | β | β |
| Return on assets | β7.6% | β12.3% | β42.2% | β18.2% | β32.9% | β50.4% | β5.1% | 30.3% | 11.2% | β44.9% |
| Return on tangible equity | β43.5% | β79.3% | β | β | β | β | β | β | β | β |
| Growth | ||||||||||
| Revenue growth | β | 73.5% | 1,447.5% | 580.1% | β44.2% | β4.8% | 12.5% | 64.8% | 19.0% | β19.6% |
| Net income growth | β | β | β | β | β | β | β | β | β63.3% | β357.2% |
| EPS growth | β | β | β | β | β | β | β | β | β62.8% | β322.3% |
| FCF growth | β | β465.8% | β | β | β | β | β | β599.9% | β | β |
| Share count change | β | 1.8% | 9.0% | 36.6% | 20.2% | 11.7% | 2.8% | 13.7% | β1.5% | 15.9% |
| Financial health | ||||||||||
| Debt / equity | 0.8x | 1.0x | β | β | β | β | β | β | β | β |
| Interest coverage | β8.1x | β | β | β | β | β | β | β | β | β |
| Current ratio | 0.8x | 0.7x | 0.5x | 0.3x | 0.4x | 0.2x | 0.3x | 0.5x | 0.5x | 0.4x |
| Quick ratio | 0.8x | 0.5x | 0.3x | 0.2x | 0.3x | 0.2x | 0.3x | 0.4x | 0.5x | 0.3x |
| Capital allocation | ||||||||||
| Capex / revenue | 3,267.7% | 301.6% | 23.1% | 0.0% | 0.0% | 1.5% | 1.2% | 9.6% | 4.4% | 12.3% |
| Stock comp / revenue | 1,829.1% | 621.1% | 33.4% | 13.2% | 25.1% | 23.6% | 2.0% | 1.2% | 4.6% | 25.3% |
| Payouts / FCF | β | β | β | β | β | β | 91.2% | β | β | β |
| Quality scores | ||||||||||
| Piotroski F-score | β | 1.0 | 4.0 | 3.0 | 3.0 | 3.0 | 7.0 | 4.0 | 4.0 | 2.0 |
| Altman Z'' | β1.9 | β | β | β | β | β | β | β | β | β |
| Accruals ratio | β13.2% | 7.2% | β39.5% | β0.6% | β30.7% | β36.6% | β7.8% | 33.3% | 19.3% | β25.7% |
Source: SEC EDGAR XBRL filings (CIK 0001321851). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. Filed in CNY under US GAAP and converted to US$: income and cash-flow lines at each period's average exchange rate, balance-sheet lines at the period-end rate. For information only β not investment advice. Check the original filings before relying on any figure.